School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
PreventionGenetics, Marshfield, Wisconsin, USA.
Clin Genet. 2022 Apr;101(4):429-441. doi: 10.1111/cge.14119.
The aim of this study was to explore kidney failure (KF) in Bardet-Biedl syndrome (BBS), focusing on high-risk gene variants, demographics, and morbidity. We employed the Clinical Registry Investigating BBS (CRIBBS) to identify 44 (7.2%) individuals with KF out of 607 subjects. Molecularly confirmed BBS was identified in 37 KF subjects and 364 CRIBBS registrants. KF was concomitant with recessive causal variants in 12 genes, with BBS10 the most predominant causal gene (26.6%), while disease penetrance was highest in SDCCAG8 (100%). Two truncating variants were present in 67.6% of KF cases. KF incidence was increased in genes not belonging to the BBSome or chaperonin-like genes (p < 0.001), including TTC21B, a new candidate BBS gene. Median age of KF was 12.5 years, with the vast majority of KF occurring by 30 years (86.3%). Females were disproportionately affected (77.3%). Diverse uropathies were identified, but were not more common in the KF group (p = 0.672). Kidney failure was evident in 11 of 15 (73.3%) deaths outside infancy. We conclude that KF poses a significant risk for premature morbidity in BBS. Risk factors for KF include female sex, truncating variants, and genes other than BBSome/chaperonin-like genes highlighting the value of comprehensive genetic investigation.
本研究旨在探讨 Bardet-Biedl 综合征(BBS)中的肾衰竭(KF),重点关注高危基因突变、人口统计学特征和发病率。我们利用临床注册研究 Bardet-Biedl 综合征(CRIBBS),在 607 名受试者中发现 44 名(7.2%)患有 KF 的个体。在 37 名 KF 患者和 364 名 CRIBBS 登记患者中鉴定出分子证实的 BBS。KF 与 12 个基因的隐性致病变异有关,BBS10 是最主要的致病基因(26.6%),而 SDCCAG8 的疾病外显率最高(100%)。在 67.6%的 KF 病例中存在两种截断变异。不属于 BBSome 或分子伴侣样基因的基因中 KF 的发病率增加(p < 0.001),包括 TTC21B,这是一个新的候选 BBS 基因。KF 的中位年龄为 12.5 岁,绝大多数 KF 在 30 岁之前发生(86.3%)。女性受影响的比例不成比例(77.3%)。虽然识别出了不同的尿路疾病,但在 KF 组中并不更常见(p = 0.672)。在婴儿期以外的 15 例死亡中,有 11 例(73.3%)出现 KF。我们的结论是,KF 对 BBS 患者的过早发病构成重大风险。KF 的危险因素包括女性、截断变异和 BBSome/分子伴侣样基因以外的基因,这突出了全面遗传研究的价值。